Methotrexate Polyglutamate Concentrations in Erythrocytes Are a Potential Tool for Therapeutic Drug Monitoring of Methotrexate Response in Rheumatoid Arthritis.

被引：0
|
作者：
De Rotte, C. F. J. [1 ]
den Boer, Ethan [2 ]
Bulatovic, Maja [3 ]
Pluijm, Saskia M. F. [1 ]
Hazes, Johanna M. W. [1 ]
De Jonge, Robert [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Erasmus Univ Hosp, Rotterdam, Netherlands
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2161
引用
收藏
页码：S914 / S914
页数：1
相关论文
共 50 条
  • [41] Assessment of Erythrocytes Methotrexate Polyglutamate Three Levels in Psoriatic Patients Treated with Methotrexate Monotherapy and Their Association with Disease Response
    Goud, Veera Krishna
    Goud, Alladi Charanraj
    Ramassamy, Sivaranjini
    Jayanthi, M.
    Medha, R.
    Chandrashekar, Laxmisha
    [J]. INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2024,
  • [42] Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response
    Yan, Huanhuan
    Su, Rui
    Xue, Hongwei
    Gao, Chong
    Li, Xiaofeng
    Wang, Caihong
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [43] Measurement of erythrocyte methotrexate polyglutamate levels: Ready for clinical use in rheumatoid arthritis?
    Danila M.I.
    Hughes L.B.
    Brown E.E.
    Morgan S.L.
    Baggott J.E.
    Arnett D.K.
    Bridges Jr. S.L.
    [J]. Current Rheumatology Reports, 2010, 12 (5) : 342 - 347
  • [44] Methotrexate polyglutamate concentrations and association with disease control in rheumatoid arthritis: comment on the article by Stamp et al Reply
    Stamp, Lisa K.
    Barclay, Murray L.
    O'Donnell, John L.
    Chapman, Peter T.
    Frampton, Christopher
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (08): : 2560 - +
  • [45] Methotrexate Reduces the Frequency of Prediabetes in Patients with Rheumatoid Arthritis or Psoriatic Arthritis.
    Perdan-Pirkmajer, Katja
    Pirkmajer, Sergej
    Hocevar, Alojzija
    Rotar, ZIga
    Gaspersic, Natasa
    Praprotnik, Sonja
    Tomsic, Matija
    Ambrozic, Ales
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S223 - S223
  • [46] Monitoring methotrexate therapy in patients with rheumatoid arthritis
    Wiela-Hojenska, A
    Orzechowska-Juzwenko, K
    Swierkot, J
    Wiland, P
    Hurkacz, M
    Szechinski, J
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2004, 42 (08) : 434 - 441
  • [47] THERAPEUTIC DRUG-MONITORING OF METHOTREXATE
    STUART, JFB
    MCVIE, JG
    CALMAN, KC
    LAWRENCE, JR
    STEELE, WH
    [J]. BRITISH JOURNAL OF CANCER, 1980, 42 (01) : 192 - 192
  • [48] Drug combinations with methotrexate to treat rheumatoid arthritis
    Rath, T.
    Rubbert, A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S52 - S57
  • [49] Methotrexate - Anchor Drug in the Treament of rheumatoid Arthritis
    Fiehn, Christoph
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (03) : 193 - 195
  • [50] Update on Methotrexate as the Anchor Drug for Rheumatoid Arthritis
    Pincus, Theodore
    Gibson, Kathryn A.
    Castrejon, Isabel
    [J]. BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2013, 71 : S9 - S19
12345